Sickle Cell Anemia Research | sciencenewsnet.in

Breaking News

Where Did Americans Find Information for the 2024 Election?

Artificial “mini-hearts” take flight to the International Space Station

Stephen Wolfram presents at the American Academy of Arts and Sciences for the Hertz Foundation’s Empowering Excellence Event

MSU experts: How consumers and retailers can prepare for the holidays

Program at Rutgers Supporting Veterans Facing Challenges Bolstered by $1 Million Grant

Giving Veterans a Reason to Smile

Rethinking electric bus depots as ‘profitable energy hubs’

“The sound of neurons”: Q&A with Beckman Director Steve Maren

For Layered 2D Materials, Robotics Produces Cleaner Interfaces Between Stacked Sheets

ADHA Objects to ADA Non-Hygienist Staffing Resolutions, Calls for Constructive Collaboration

06 Nov, 2024

Reaching toward a cure for sickle cell disease

April 2, 2020 sarah JonasFeature

The National Heart, Lung, and Blood Institute (NHLBI) has awarded Case Western Reserve University up to $3.7 million to assess emerging genome-editing based therapies being tested for curing sickle cell disease (SCD) at leading U.S research universities and hospitals.

SCD is the most well-known among a group of inherited blood disorders, affecting about 100,000 people in the United States and about 20 million worldwide, according to a 2018 National Institutes of Health (NIH) statement announcing the NHLBI Cure Sickle Cell Initiative.

While Promoting Diseases Like Cancer, These Enzymes Also Cannibalize Each Other

January 20, 2020January 21, 2020 sarah JonasResearch Results

In diseases like cancer, atherosclerosis, and sickle cell anemia, cathepsins promote their propagation. Drug trials to inhibit these enzymes have failed due to baffling side effects. Now a new study examines cathepsins in systems to remove some of the bafflement.